Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Allogene Therapeutics (ALLO) Interest Coverage Ratio (2024 - 2025)

Historic Interest Coverage Ratio for Allogene Therapeutics (ALLO) over the last 2 years, with Q3 2025 value amounting to 130.53.

  • Allogene Therapeutics' Interest Coverage Ratio rose 8181.43% to 130.53 in Q3 2025 from the same period last year, while for Sep 2025 it was 269.75, marking a year-over-year increase of 9094.24%. This contributed to the annual value of 1509.39 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Allogene Therapeutics' Interest Coverage Ratio is 130.53, which was up 8181.43% from 212.01 recorded in Q2 2025.
  • In the past 5 years, Allogene Therapeutics' Interest Coverage Ratio registered a high of 130.53 during Q3 2025, and its lowest value of 746.79 during Q4 2024.